People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| REGENXBIO Inc. | — | Biotechnology | Series C | $105.9M | $2.9B | 2013 |
Kenneth T. Mills at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth T. Mills on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Donald J. Hayden, Jr. | 1 | 5 |
| John Daniel Kiser | 1 | 3 |
| Allan M. Fox | 1 | 3 |
| Camille J. Samuels | 1 | 2 |
| Daniel T. Kiser | 1 | 1 |
| Luke J. Beshar | 1 | 1 |
| Allan T. Fox | 1 | 1 |
| Don T. Hayden | 1 | 1 |
| Benjamin T. Auspitz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.